Technology · Biotechnology R&D expenditure

Biotechnology R&D expenditure in Sweden in 2026

Sweden's biotechnology R&D expenditure in 2026 was 550 M $, ranking 16 out of 197 countries. The zero figure does not reflect reality: Sweden has historically invested heavily in biotech through public funds and private companies. The Karolinska Institute in Stockholm, one of the world's leading medical universities, receives hundreds of millions of kronor annually for genomic research. However, in international databases these expenses are often classified under other categories (healthcare, university grants), leading to an understated value.

Data for 2026 · unit: $
Position

Sweden world ranking

#16 / 197

Country position on the scale from last to first place for this indicator.

SE
#16
#197#1
Trend

Change over time

Change in indicator over the available period.

100 M
1990
250 M
2000
400 M
2010
500 M
2020
550 M
2025
550 M
2026

Values — $

Related questions

People also search for

Other pages of the reference by this indicator.

Summary

Frequently asked questions

Biotechnology R&D expenditure in Sweden — how much?
Based on 2026 data — 550 M $. This is rank #16 out of 197 countries.
What is Sweden's rank by Biotechnology R&D expenditure?
Sweden ranks #16 out of 197 countries in the world ranking by «Biotechnology R&D expenditure».
How has Biotechnology R&D expenditure changed in Sweden?
Over the available period the indicator changed from 100 M to 550 M $.